Síndrome de Klippel-Trenaunay en gestante, a propósito de un caso / Klippel-Trenaunay syndrome in pregnant woman, about a case

Introducción: El síndrome de Klippel-Trenaunay es un trastorno neurocutáneo que se asocia a complicaciones trombóticas y hemorrágicas graves durante la gestación. Principales síntomas y/o hallazgos clínicos: Presentamos el caso de una primigesta afecta del síndrome de Klippel-Trenaunay a la que se realizó un seguimiento estrecho del embarazo de forma conjunta con el Servicio de Medicina Física y Rehabilitación. Ingresó a la 39+2 semanas por rotura de membranas que finalizó mediante parto vaginal eutócico, con aplicación de anestesia epidural sin complicaciones. Diagnósticos principales: Desde que el síndrome de Klippel-Trenaunay fue descrito por primera vez en 1900, se han informado menos de cien embarazos de pacientes afectas de esta patología en todo el mundo. A pesar del incremento del riesgo obstétrico y la posibilidad de exacerbación de las manifestaciones propias del síndrome durante la gestación, son posibles unos buenos resultados obstétricos con un asesoramiento adecuado y un seguimiento estrecho de la gestación. Intervenciones terapéuticas y resultados: Es fundamental realizar una valoración individualizada del riesgo-beneficio de la tromboprofilaxis dadas las potenciales complicaciones hemorrágicas y trombóticas que pueden sufrir estas pacientes. Conclusión: Es necesario un asesoramiento preconcepcional cuidadoso así como una atención intraparto y posparto sistemática para reducir la morbimortalidad en estas pacientes. (AU)

Introduction: Klippel-Trenaunay syndrome is a neurocutaneous disorder that is associated with severe thrombotic and hemorrhagic complications during pregnancy. Main symptoms and/or clinical findigns: We present the case of a primigravida affected by Klippel-Tre-naunay syndrome in whom a follow-up of the pregnancy was carried out jointly with the Physical Medicine and Rehabilitation Service. She was admitted at 39+2 weeks due to rupture of the membra-nes which ended with eutocic vaginal delivery, with the application of epidural anesthesia without complications.Main diagnoses: Since the Klippel-Trenaunay syndrome was first described in 1900, less than one hundred pregnancies of patients affected by this pathology have been reported worldwide. Despite the increased obstetric risk and the possibility of exacerbation of the syndrome’s own manifestations during pregnancy, good obstetric outcomes are possible with appropriate counseling and close moni-toring of pregnancy.Therapeutic interventions and results:It is essential to carry out and individualized assessment of the risk-benefit of thromboprophylaxis given the potential bleeding and thrombotic complications that these patients may suffer.Conclusion: Careful preconception counseling as well as systematic intrapartum and postpartum care are necessary to reduce mortality and morbidity in these patients. (AU)

Diagnosis and Management of Postpartum Retroperitoneal Hematoma: A Report of 3 Cases.

BACKGROUND The retroperitoneal hematoma is a very rare entity in obstetrics. A type of obstetric hematoma that extends into the retroperitoneal space, this hematoma usually occurs after laceration of the uterine artery, after uterine rupture, or by extension of a vaginal hematoma. Although the hematoma usually manifests as intense abdominal pain, sometimes the clinical signs can go unnoticed. This is the main reason it is important to report the cases in which retroperitoneal hematomas occur. In addition to clinical suspicion, experience in management can also help improve maternal morbidity and mortality from this cause. CASE REPORT We present a series of 3 clinical cases in which retroperitoneal hematomas occurred after instrumental deliveries. The 3 clinical cases described took place before the COVID-19 pandemic. In the first 2 deliveries, a vacuum was used, while in the third delivery, spatulas were used. CONCLUSIONS Our findings showed that suspicion is essential in patients with symptoms of nonspecific pain, as well as in patients with anemia that causes hemodynamic instability in the immediate postpartum period. The use of early computed tomography angiography in hemodynamically stable patients is essential to reach a diagnosis and to determine if the patient can be treated by embolization of the bleeding vessel.

Utility of indocyanine green as a single tracer for sentinel node biopsy in endometrial cancer.

AIM: Our study aims to investigate the safety and effectiveness of sentinel lymph node biopsy using indocyanine green (ICG) for the surgical staging of early-stage endometrial cancer in comparison to technetium-99 m use. METHODS: We conducted an observational retrospective study with patients diagnosed of endometrial cancer and FIGO stages I-II. All participants were injected technetium-99m the day prior to the surgery and underwent lymphoscintigraphy along with single-photon emission computed tomography. In addition, all patients were administered intraoperatively ICG injection to detect sentinel lymph node biopsy. The surgical staging was then completed according to the European Society for Medical Oncology preoperative risk category. Data obtained from the analysis of technetium-99m detection was compared to ICG detection. RESULTS: A total of 53 women with endometrial cancer were included in the study, 49 (92.5%) of them showed drainage preoperatively in the single-photon emission computed tomography and/or lymphoscintigraphy. The intraoperative bilateral detection rate for technetium-99 m was 26 (49.1%) patients compared to 40 (75.5%) patients with ICG (p = 0.013). We observed a 42.5% increase in the mean number of lymph nodes retrieved by ICG compared to technetium-99m (2.85 vs 2,0 nodes; p = 0.002). We intraoperatively identified 164 lymph nodes, 104 (63.4%) located in both obturator areas and external iliac vessels. CONCLUSION: The use of ICG for the performance of sentinel node biopsy in patients with endometrial cancer seems safe and could be superior to technetium-99 m, since it offers a higher bilateral detection rate and nodal retrieval, resulting in the possibility to perform safely less full staging lymphadenectomies.

Angioedema hereditario tipo III en una embarazada: a propósito de un caso / Hereditary angioedema type III in pregnant women: case report and literature review

Resumen ANTECEDENTES: El angioedema hereditario es una enfermedad rara, caracterizada por episodios recurrentes de edema en cualquier parte del cuerpo, sobre todo en las extremidades, la cara y las vías respiratorias. Existen tres tipos de enfermedad en función de su causa, el menos frecuente es el III con un nivel y función del inhibidor de C1 normales. Su fisiopatología es poco conocida; por lo tanto, su diagnóstico es difícil. Su tratamiento ha avanzado en los últimos años, aunque queda mucho por definir, sobre todo durante el embarazo. OBJETIVO: Evaluar la bibliografía disponible relacionada con el angioedema hereditario y su atención médica en mujeres embarazadas. CASO CLÍNICO: Paciente de 30 años, en curso de su primer embarazo. El único antecedente personal destacable fue haber padecido angioedema hereditario tipo III, diagnosticado 10 años antes después de varios episodios de angioedema orofacial. A lo largo del embarazo sobrevinieron varias crisis de la enfermedad que requirieron tratamiento de los episodios agudos y de mantenimiento en el tercer trimestre. Por último, ocurrió un parto instrumentado mediante vaccum, por riesgo de pérdida de bienestar fetal con buen desenlace materno y fetal en el posparto inmediato. CONCLUSIONES: El angioedema hereditario tipo III es una enfermedad muy rara y poco conocida en la Ginecoobstetricia que requiere establecer un protocolo y estandarización de la atención clínica, sobre todo en las embarazadas, lo que ayudará a proporcionar una información y asistencia de calidad a estas pacientes.

Abstract BACKGROUND: Hereditary angioedema is a rare disease characterized by recurrent episodes of edema anywhere in the body, especially in the extremities, face and airways. There are three types of the disease depending on its cause, the most infrequent being III with normal C1 inhibitor level and function. Its pathophysiology is poorly understood; therefore, its diagnosis is difficult. Its treatment has advanced in recent years, although much remains to be defined, especially during pregnancy. OBJECTIVE: To evaluate the available literature related to hereditary angioedema and its medical care in pregnant women. CLINICAL CASE: 30-year-old female patient, during her first pregnancy. The only personal history of note was hereditary angioedema type III, diagnosed 10 years earlier after several episodes of orofacial angioedema. Throughout the pregnancy, several crises of the disease occurred, requiring treatment in acute episodes and maintenance treatment in the third trimester. Finally, one delivery was instrumented by vaccum, due to risk of loss of fetal well-being with good maternal and fetal outcome in the immediate postpartum period. CONCLUSIONS: Hereditary angioedema type III is a very rare and little-known disease that requires establishing a protocol and standardization of clinical care, especially in pregnant women, which will help to provide quality information and assistance to these patients.

Epistaxis grave durante el embarazo, resistente al tratamiento: reporte de un caso y revisión bibliográfica / Refractory severe epistaxis during pregnancy: a case report and a literature review

Resumen ANTECEDENTES: La epistaxis durante el embarazo, aparte de ser una urgencia, tiene una prevalencia tres veces superior a la de la población general. Se controla con medidas conservadoras, aunque a veces deben indicarse tratamientos que implican intervenciones quirúrgicas. CASO CLÍNICO: Paciente de 37 años, con embarazo de 37 semanas, que acudió a Urgencias por epistaxis, sin reacción a las técnicas conservadoras (taponamiento nasal de diversa índole), que provocó anemia progresiva y requirió ligadura de la arteria esfenopalatina para detener el sangrado. Enseguida se llevó a cabo la cesárea, indicada por rotura prematura de membranas e imposibilidad de realizar la maniobra de Valsalva; nació un varón con Apgar 9-10-10. La paciente continuó con alteraciones en la anatomía de los senos paranasales debido a la intervención quirúrgica y en seguimiento en consulta de Otorrinolaringología. CONCLUSIONES: La epistaxis, aunque es un evento frecuente durante el embarazo, puede afectar a la madre y su hijo; por tanto, es importante conocer los tratamientos disponibles al respecto, notificar los nuevos casos y el tratamiento para aumentar el conocimiento de esta alteración infrecuente pero grave.

Abstract BACKGROUND: Epistaxis is a frequent emergency, which prevalence during pregnancy is three times higher than the general female population. It is usually managed with conservative measures, but sometimes more aggressive treatments like surgery may be required. Due to the limited bibliography currently available, new cases and their management should be recorded in order to assess outcomes. CASE REPORT: A 37-week-old pregnant woman went to the Emergency Department with an epistaxis that did not stop despite the use of conservative techniques. As a result of progressive anemization a sphenopalatine artery ligation was required to stop the bleeding. A cesarean section was performed for premature rupture of membranes and the impossibility of Valsalva maneuver. A male infant was born with APGAR test results of 9-10-10. During follow up the patient presented changes in the anatomy of her paranasal sinuses caused by the sphenopalatine artery ligation and is being followed up by Ear-Nose-Throat specialist. CONCLUSION: Epistaxis during pregnancy rarely leads to maternal and/or fetal involvement; it is therefore essential to know all treatments available as well to record new cases and their management to increase knowledge about this uncommon but severe pathology.

Úlcera de Lipschütz: reporte de un caso y revisión bibliográfica / Lipschütz Ulcer: a case report and a literature review

Resumen: ANTECEDENTES: Las úlceras de Lipschütz son lesiones vulvovaginales dolorosas, de aparición aguda y desaparición espontánea en 2 a 6 semanas, no dejan secuelas ni son recurrentes a largo plazo. Su etiopatogenia es incierta, alrededor de 70% se consideran idiopáticas. En los estudios más recientes se ha demostrado su asociación con agentes infecciosos, sobre todo con el virus de Epstein-Barr. El diagnóstico se establece por exclusión y su tratamiento se basa en el control sintomático, cicatrizantes, analgésicos y antisépticos. CASO CLÍNICO: Paciente de 15 años, con úlceras vulvares de aparición súbita acompañadas de cuadro catarral. Se indicó tratamiento local con cicatrizante, antiséptico y antiinflamatorio; al cabo de tres semanas se observó la desaparición de las lesiones y la negatividad de las pruebas que descartó el origen infeccioso. Se estableció el diagnóstico de úlcera de Lipschütz. CONCLUSIONES: La úlcera de Lipschütz es infrecuente y los niños son quienes más la padecen. Debido al carácter de desaparición espontánea y a la juventud de las pacientes, es decisivo establecer el correcto diagnóstico diferencial.

Abstract: BACKGROUND: Lipschütz Ulcers are painful, acute onset and self-limiting vulvovaginal lesions that can frequently be associated with prodromal symptoms, disappearing in 2-6 weeks without any sequelae. 70% of cases present idiopathic etiopathogenesis, and are related to Epstein-Barr virus, among others. The diagnosis is made by exclusion and its treatment is based on symptomatic control and the promotion of correct healing, using analgesics, cicatrizers and antiseptics. CASE REPORT: A 15-year-old girl reported the acute apparition of ulcerative vulvar lesions coinciding with systemic catarrhal symptoms. Local treatment with healing, antiseptic and anti-inflammatory lotions was prescribed, and after three weeks, she was reevaluated, observing the disappearance of the lesions and the negativity of the tests to rule out infectious origin, for which she was diagnosed with a Lipschütz ulcer. CONCLUSIONS: Lipschütz ulcer is rare and children are the ones who suffer most from it. Due to the spontaneous disappearance character and the youthfulness of the patients, it is decisive to establish the correct differential diagnosis.

Safety and patients' satisfaction after hysteroscopic sterilisation.

The aim of this study was to understand the potential complications of the Essure® device as well as the factors influencing its onset and patient satisfaction. We present a 9-year descriptive prospective study that included 1068 patients. The device was placed in 1056 of them (98.8%); 894 had no pain or mild pain during the insertion and only 12 patients experienced pain greater than menstrual pain. The proportion of patients without pain was greater in the group that took NSAIDs or NSAIDs and BZD and the unmedicated group had the highest rate of severe pain (p = .00). In all, 161 of the 1064 patients who had the Essure® inserted reported having an adverse effect during the 3-months post-insertion (pelvic pain or discomfort). The mean score out of 10 attributed to this method was 9.06 (S = 1.11). We concluded that the Essure® shows a low rate of complications and users showed a high degree of satisfaction. Impact statement What is already known on this subject: There are few international publications on Essure®. When we conducted a search in PubMed for the term 'Essure', we obtained 221 publications. When we added the terms 'Essure and complications', we obtained 20 publications, and when we increased the restriction including 'satisfaction', we obtained seven; thus, the uniqueness of our study. What the results of this study add: We present a 9-year descriptive prospective study that included 1068 patients. The aim of this study was to understand the potential complications of the Essure® device (Bayer, Whippany, NJ), as well as factors that can influence its onset and the patient satisfaction. The device was placed in 1056 of the patients (98.8%); 894 had no pain or mild pain during the insertion and only 12 patients experienced pain greater than menstrual pain. The proportion of patients without pain was greater in the group that took NSAIDs or NSAIDs and BZD and the unmedicated group had the highest rate of severe pain (p=.00). What the implications are of these findings for clinical practice and/or further research: Our study shows a low rate of complications with Essure®, mild and transient in most cases, as well as a high degree satisfaction. Nevertheless, given the few published studies on this device, we believe that long-term follow-up is needed.

Mola completa coexistente con feto vivo normal: caso clínico y revisión de la literatura / Complete mole coexisting with a live term fetus: a case report and literature review

La coexistencia de mola completa y feto vivo a término es una entidad raramente reportada en la literatura científica. El diagnóstico de sospecha se establece con la ecografía y la confirmación se logra a través del estudio anatomopatológico de tejidos. Las pacientes con mola completa tienen un riesgo del 12-20% de desarrollar enfermedad trofoblástica persistente, de ahí la importancia del seguimiento estrecho. Presentamos un caso de diagnóstico precoz de mola completa coexistente con gestación normal y revisamos la literatura disponible del tema (AU)

The coexistence of a complete mole and live term fetus is a rare entity seldom reported in the literature. Primary non-invasive diagnosis is usually achieved through ultrasound examination and definitive diagnosis can be achieved when molar tissue samples are available for histopathological examination. Patients with a complete mole have a 12-20% risk of developing persistent gestational trophoblastic disease, hence the importance of close follow-up. We report the early diagnosis of a complete mole coexisting with a normal fetus and also provide a review of the literature on the topic (AU)